€2bn credit facility for Degussa
Germany's third largest chemical company has raised € 2 bn of
credit lines by means of a syndicated facility with a group of
leading international banks.
Chiron collars PowderJect
Chiron's has completed its acquisition of UK vaccine and drug
delivery specialist PowderJect, making it the second-largest
manufacturer of flu vaccines worldwide.
Whatman liquidates German unit
Whatman has decided to wind down the operations of its German
subsidiary Biometra, taking a £10.1 million charge in the process.
The move fends off a patent infringement challenge from Applied
Nitto Denko buys Elan's patch business
Nitto Denko is to buy Elan Transdermal Technologies in the first
stage of a strategy to roll-out Nitto's drug delivery technologies
around the world.
Orion closes down Danish manufacturing
Troubled Finnish group Orion has decided to close down its
pharmaceutical manufacturing operations in Denmark in a bid to save
Caliper gets OK for Zymark purchase
Caliper Technologies has been given the go-ahead by the US federal
Trade Commission for its $71 million cash and stock acquisition of
Zymark, a specialist in laboratory automation and robotics
DSM takes stake in chiral compound specialist
DSM has taken a 25 per cent interest in Nijmegen, Netherlands-based
Chiralix in move which both expands DSM's capabilities in
early-stage drug development and Chiralix' position in
Biotrace taps into Scandinavia with Maltec buy
Microbiology specialist Biotrace has continued its expansion into
the healthcare sector with the acquisition of Denmark's Maltec,
helping it to target Scandinavia's strong pharma sector
Pfizer to sell Pharmacia diagnostics unit
Pfizer is considering the sale of its Pharmacia Diagnostics
business, acquired alongside the rest of Pharmacia in a $60 billion
deal that concluded in April.
McCormick sells packaging ops to Kerr
US food company McCormick & Co looks set to sell its packaging
activities to Kerr Group in a transaction valued at $142.5 million.
Panic offer seals ICN Bio deal
Former Yugoslav prime minister Milan Panic, who until recently had
been at the helm of ICN Pharmaceuticals for 42 years, has bought
the ICN Biomedicals division for $15 million.
Novo facility covers a third of bulk insulin market
Novo Nordisk has sent out the first batch of bulk insulin from a
new facility at its site in Kalundborg, Denmark, that is producing
more than a third of the world's supply.
IDEC and Biogen forge biggest bio pairing in 2003
The resurgence of merger and acquisition activity in the biotech
industry shows little sign of letting up, with US companies IDEC
Pharmaceuticals and Biogen the latest to step up to the altar
Cell culture markets get lift from BSE fears
The market for cell culture products is getting a lift from
stringent regulations from the US FDA and Department of
Agriculture, restricting the importation and usage of foetal bovine
Iggesund sees OTC trend key to future growth
There is a growing trend towards patients self-medicating with
over-the-counter products rather than asking their doctors for a
prescription medication, and this promises to benefit companies
involved in pharmaceutical packaging,...